4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
A quantitative model of thrombosis in intracranial aneurysms (THROMBUS)
Date du début: 1 févr. 2011, Date de fin: 30 avr. 2014,
Rupture risk of intracranial aneurysms (IA) has been studied at length. However, very little is known about the healing mechanism, namely the formation of a clot inside the cavity after insertion of a stent. The multiscale interaction between biological and hemodynamic processes is the central ingredient of this proposal. The core of the project is to develop and validate a biological model of spo ...
Voir le projet
10
Participants partenaires
TERMINÉ
Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children (LOULLA&PHILLA)
Date du début: 1 nov. 2008, Date de fin: 30 avr. 2012,
"Only for Children Pharmaceuticals, a French based Small and Medium-sized Enterprise (SME) developing drug for children, is the Coordinator of a multinational, multidisciplinary and complementary Consortium. This Consortium is composed of highly qualified organizations and notorious clinicians in pediatric hemato-oncology. The Consortium is an integrated team of competencies (clinicians, pædiatric ...
Voir le projet
12
Participants partenaires
TERMINÉ
Development of targeted DNA-Chips for High Throughput Diagnosis of NeuroMuscular Disorders (NMD-Chip)
Date du début: 1 oct. 2008, Date de fin: 30 sept. 2011,
Inherited Neuromuscular Diseases (NMD) form a large group of diseases including Limb-Girdle Muscular Dystrophies (LGMD), Congenital Muscular Dystrophies (CMD), Duchenne and Becker Muscular Dystrophies (DMD/BMD), or Charcot-Marie-Tooth disease (CMT). Within a given disease group genetic and clinical heterogeneity is the hallmark. The precise diagnostic of neuromuscular diseases thus requires extens ...
Voir le projet
13
Participants partenaires
TERMINÉ
PATIENT SAFETY THROUGH INTELLIGENT PROCEDURES IN MEDICATION (PSIP)
Date du début: 1 janv. 2008, Date de fin: 31 juil. 2011,
Adverse Drug Events (ADE) due to product safety problems, and medication errors due to human factors (HF) are a major Public Health issue. They endanger the patients' safety and originate considerable extra hospital costs.Healthcare ICT applications should help reducing the prevalence of preventable ADE, by providing healthcare professionals and patients with relevant knowledge (guidelines, recomm ...
Voir le projet